choroideremia
Biogen Phase III choroideremia study did not meet primary endpoint
June 15, 2021Manufacturing and Production Biogen, choroideremia, phase III
Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …
Gene trial ‘restores sight’
January 17, 2014Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes
A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
